26.12.2013 Views

Chapter 18

Chapter 18

Chapter 18

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Chapter</strong> <strong>18</strong><br />

Eucaryotic Viruses and other<br />

acellular infectious agents<br />

11-25-2008<br />

11-26-2008<br />

1


Taxonomy of Eucaryotic Viruses<br />

• most of the ~5,000 known viruses infect<br />

eucaryotic organisms<br />

• Virus classification by the ICTV<br />

• Genome structure<br />

• Replication strategy<br />

• Morphology<br />

• Genetic relatedness<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 2


Viruses that Infect Vertebrates<br />

Figure <strong>18</strong>.1<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 3


Reproduction of Animal Viruses<br />

• adsorption<br />

• penetration and uncoating<br />

• replication of virus nucleic acids<br />

• synthesis and assembly of virions<br />

• virion release<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 4


Table <strong>18</strong>.1<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 5


Penetration and Uncoating<br />

• fusion of envelope with host cell<br />

membrane<br />

Fig <strong>18</strong>.4<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 6


Endocytosis – enveloped virus<br />

Figure <strong>18</strong>.4 (b)<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 7


Endocytosis – naked virus<br />

Figure <strong>18</strong>.4 (c)<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 8


Replication and transcription in DNA Viruses<br />

- Herpes simplex virus I<br />

uses host RNA<br />

polymerase for<br />

synthesis of viral<br />

mRNA<br />

uses virusencoded<br />

DNA<br />

polymerase for<br />

genome replication<br />

Figure <strong>18</strong>.6<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 9


Poxviruses<br />

• large, morphologically complex doublestranded<br />

DNA (dsDNA) viruses<br />

• virion carries DNA-dependent RNA<br />

polymerase that synthesizes early<br />

mRNA<br />

• encodes DNA polymerase and other<br />

enzymes needed for DNA replication<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 10


Hepadnaviruses- HBV<br />

• circular, partial dsDNA genome<br />

• transcribed by host RNAP<br />

• generates several mRNA molecules<br />

• one for pregenome RNA<br />

• others encode polymerase with reverse<br />

transcriptase activity<br />

• pregenome converted to dsDNA by virus polymerase<br />

(+RNA -DNA 2S DNA)<br />

11


Replication and Transcription<br />

in RNA Viruses<br />

• very diverse reproductive strategies<br />

• four general modes of replication and<br />

transcription<br />

12


Pico-RNA<br />

Para- and ortho-<br />

Myxo- affinity to mucin<br />

Respiratory-enteric-orphan<br />

Figure <strong>18</strong>.8<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 13


Assembly of Virus Capsids<br />

• late genes direct capsid protein<br />

synthesis which spontaneously selfassemble<br />

to form the capsid<br />

• during icosahedral virus assembly<br />

empty procapsids form first, nucleic acid<br />

are then inserted<br />

• assembly of envelope viruses<br />

• in most cases, similar to assembly of<br />

naked viruses<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 14<br />

• site of morphogenesis varies


Figure <strong>18</strong>.2<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 15


Virion Release<br />

• naked viruses<br />

• usually by lysis of host cell<br />

• envelope viruses<br />

• formation of envelope and release usually<br />

occur concurrently (budding)<br />

• virus-encoded proteins incorporated into host<br />

membrane<br />

• nucleocapsid buds outward and is surrounded<br />

by modified host membrane<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 16


Release of influenza virus by budding<br />

Figure <strong>18</strong>.11<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 17


HIV release<br />

by budding<br />

Figure <strong>18</strong>.12 (a)<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display <strong>18</strong>


Mechanisms of host cell damage<br />

and cell death<br />

• inhibition of host DNA, RNA, and protein<br />

synthesis<br />

• lysosome damage<br />

• causes release of hydrolytic enzymes<br />

• alteration of plasma membrane<br />

• lead to attack of host by immune system<br />

• lead to cell fusion, forming syncytium<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 19


Other mechanisms…<br />

• toxicity from high concentrations of viral<br />

proteins<br />

• formation of inclusion bodies<br />

• can disrupt cell structure<br />

• the Negri bodies in rabies infected neurons<br />

• chromosomal disruptions<br />

• transform host cell into malignancy<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 20


Types of viral infections (Fig. <strong>18</strong>.3)<br />

• acute infections<br />

• rapid onset and relatively short duration<br />

• persistent infections- last many years<br />

• Chronic infection, e.g, HBV infection<br />

• Latent infection, e.g., Herpes virus infection<br />

-<br />

21


Types of persistent infections<br />

• chronic virus infection<br />

• virus almost always detectable<br />

• clinical symptoms mild or absent for long<br />

periods<br />

• latent virus infection<br />

• virus stops reproducing and remains<br />

dormant for some time<br />

• during latency, symptoms, antivirusantibodies,<br />

and viruses are not detectable<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 22


Possible causes of persistent<br />

infections<br />

• integration of viral genome into host<br />

genome<br />

• decrease in antigenicity of virus<br />

• mutation to less virulent and slower<br />

reproducing form<br />

• defective interfering (DI) particle – deletion<br />

mutant that cannot reproduce and slows<br />

reproduction of normal virus<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 23


Slow virus diseases<br />

• Symptoms take years to emerge<br />

• subacute sclerosing panencephalitis caused<br />

by measles virus<br />

• HIV infections<br />

• Prion<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 24


Prion<br />

• A small proteinaceous infectious<br />

particle<br />

• Passes through the filter (100 nm)<br />

and still transmits disease<br />

• resistant to a wide range of<br />

chemical and physical treatment<br />

• inactivated at 121 o C 1 h


Prion-caused degenerative diseases<br />

• Scrapie<br />

• bovine spongiform<br />

encephalopathy (BSE) or<br />

mad cow disease<br />

• Creutzfeldt-Jakob<br />

disease (CJD) and<br />

variant CJD (vCJD)<br />

• Kuru<br />

Scrapie- cause intense itching<br />

- The prototype of prion<br />

- A natural progressive brain disease<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 26


Kuru- “shivering” or “ trembling”<br />

• 1950, occurred in the Fore<br />

tribe of New Guinea<br />

highlands<br />

• Related to the cannibalistic<br />

practices<br />

• Blurred speech, silly smiles,<br />

and dementia<br />

lose the ability to walk, talk, and see


The 1 st<br />

Nobel Prize for prion study<br />

• 1976, Carleton Gajdusek (1923~)<br />

• retired as chief of the laboratory of CNS at NIH<br />

• Demonstrated Kuru’s etiology<br />

• an infectious invisible slow<br />

(~ 30 y incubation period) virus as<br />

that of Scrapie?<br />

• Never saw any inflammation!


Creutzfeldt-Jakob disease (CJD)<br />

• The human form of mad cow disease<br />

• BSE (Bovine Spongiform encephalopathy)<br />

• Identified by Creutzfeldt and Jakob (1920)<br />

• A progressive fatal neurodegenerative<br />

disease<br />

• Usually aged between 50~75<br />

• Characterized by seizures, massive incoordination,<br />

dementia


Transmission of CJD<br />

• Injection with contaminated growth hormone<br />

• Transplantation of contaminated corneas<br />

• Contact with contaminated medical devices<br />

• brain electrodes- “Iatrogenic”<br />

• Ingestion of infected tissue<br />

• 1996 in UK, causes an unusual incidence of CJD in<br />

young people (


Inheritable CJD- prnp<br />

• A Gerstmann-Straussier-Scheinker syndrome<br />

• A Kuru like familial disease Inherited forms<br />

emerge earlier (~ 45 yr)<br />

• familial CJD, GSS, fatal familial insomnia (FFI)-<br />

10~15%<br />

• specific mutation of the gene on chromosome 20-<br />

prnp


Current Model<br />

of Disease Production by Prions<br />

• PrP C (prion protein): “normal” form<br />

• PrP Sc : abnormal form<br />

• entry of PrP Sc into animal brain causes<br />

PrP C to change its conformation to<br />

abnormal form<br />

• the newly produced PrP Sc convert more to<br />

the abnormal form<br />

• interactions between PrP Sc and PrP C <br />

crosslinking of PrP C neuron loss<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 32


The 2 nd Nobel prize-<br />

Prion pathogenesis<br />

• PrP sc binds to the normal PrP c<br />

on the cell surface, causing it to<br />

be processed into PrP sc - a<br />

replicating protein, to be<br />

released from the cell, and to<br />

be aggregated as amyloid-like<br />

plaques in the brain<br />

• Vacuolated neurons (loss of<br />

function and lack of an immune<br />

response)<br />

• 1997, Stanley Prusiner<br />

(1942~) for showing that<br />

PrP sc is sufficient to<br />

cause disease<br />

• Director of institute of<br />

neurodegenerative disease<br />

UCSF


Viruses and Cancer<br />

• tumor<br />

• growth or lump of tissue<br />

• neoplasia<br />

• abnormal new cell growth and reproduction due to<br />

loss of regulation<br />

• anaplasia<br />

• reversion to a more primitive or less differentiated<br />

state<br />

• metastasis<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 34<br />

• spread of cancerous cells throughout body


Carcinogenesis<br />

• complex, multistep process<br />

• often involves oncogenes<br />

• cancer-causing genes<br />

• many involved in regulation of cell growth and<br />

differentiation<br />

• some viruses contribute to carcinogenesis<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 35


Viruses implicated in human<br />

cancers<br />

Epstein-Barr virus<br />

Hepatitis B virus<br />

Hepatitis C virus<br />

Burkitt’s lymphoma<br />

nasopharyngeal<br />

carcinoma<br />

liver cancer hepatoma<br />

liver cancer<br />

Human herpesvirus 8<br />

HIV<br />

human papillomavirus<br />

HTLV-1 and HTLV-2<br />

Kaposi’s sarcoma<br />

cervical cancer<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

leukemia<br />

for reproduction or<br />

display 36


Possible mechanisms by which<br />

viruses cause cancer<br />

• carry oncogene into cell and insert it<br />

into host genome<br />

• altered cell regulation due to changes in<br />

kinase activity or production of<br />

regulatory proteins<br />

• insertion of promoter or enhancer next<br />

to cellular oncogene<br />

Copyright © The<br />

McGraw-Hill<br />

Companies, Inc.<br />

Permission required<br />

for reproduction or<br />

display 37


<strong>Chapter</strong> 37<br />

Human Diseases Caused by<br />

Viruses<br />

38


Airborne Diseases<br />

• when human is source, airborne viruses<br />

are propelled from respiratory tract by<br />

coughing, sneezing, or vocalizing<br />

39


Chickenpox (Varicella)<br />

• caused by varicella-zoster virus<br />

• results from initial infection<br />

• Attenuated vaccine<br />

40<br />

Figure 37.1


Shingles (herpes zoster)<br />

• postherpetic neuralgia<br />

• reactivated form of chickenpox<br />

Figure 37.2


Flu or common cold<br />

• clinical manifestations<br />

• chills, fever, headache, malaise, and general<br />

muscular aches and pains<br />

• recovery usually within 3 to 7 days<br />

• often leads to secondary infections by bacteria<br />

• rhinitis, tonsillitis, laryngitis, bronchitis, and<br />

pneumonia<br />

• treatment, prevention, and control<br />

• symptomatic/supportive therapy<br />

• inactivated virus vaccine<br />

42


43<br />

Influenza (Flu) by influenza virus<br />

• Orthomyxovirus (segmented virus)<br />

• Classified into A, B, and C groups<br />

• 16 HA and 9 NA<br />

• Influenza Pandemics<br />

• 19<strong>18</strong>, HswN1 (Spanish flu)<br />

• 50~ 100 million moratlity<br />

• 1947, H1N1<br />

• 1957, H2N2 (Asian flu)<br />

• 1968, H3N2 (Hong Kong flu)<br />

• 1977, H1N1 (Russian flu)<br />

• Avian flu- H5N1(1997~)


Generation of a reassortant virus<br />

- broad host range and segmented genome<br />

Reassortant virus


Avian flu virus<br />

• H9N2 (1998/1999)<br />

• China and Hong Kong<br />

• H7N7 (2003)<br />

• Netherlands<br />

• H5N1 in human<br />

(1997~2003~)<br />

• Hong Kong, China, and<br />

worldwide….<br />

• since 2003, > 300<br />

infected and > 150 died<br />

Emerging Infectious Diseases (2007) October


SARS (Severe Acute Respiratory Syndrome)<br />

• An emerging disease cause by coronavirus<br />

• Flu-like syndrome<br />

• Vaccine target?<br />

- Virus of the year (2002-2003)<br />

Where is the SARS virus??<br />

Box<strong>18</strong>.1<br />

- a mutation in spike protein<br />

46


Classification of coronaviruses<br />

• 3 groups coronaviruses:<br />

• groups 1 and 2: mammalian viruses<br />

• group 3 contains only avian viruses<br />

• Classified into distinct species by host<br />

range, antigenic relationships, and<br />

genomic organization<br />

47


Phylogenetic analyses of SARS-CoV sequences<br />

48


Measles (Rubeola)<br />

• caused by measles virus<br />

• subacute sclerosing<br />

panencephalitis<br />

• rare progressive degeneration of<br />

central nervous system caused<br />

by measles virus<br />

• treatment, prevention, and<br />

control<br />

• symptomatic/supportive therapy<br />

• attenuated measles vaccine<br />

• MMR vaccine (measles,<br />

mumps, rubella)<br />

Figure 37.3<br />

49


Mumps<br />

• caused by mumps virus<br />

• pleomorphic, enveloped<br />

virus<br />

• helical nucleocapsid<br />

• negative strand RNA<br />

Figure 37.4<br />

50


Rubella (German Measles)<br />

• caused by rubella virus<br />

• ssRNA virus<br />

• spread by respiratory droplets<br />

• congenital rubella syndrome<br />

• infection of pregnant women in<br />

first trimester<br />

• fetal death, premature delivery,<br />

and/or congenital defects<br />

• live attenuated vaccine:<br />

MMR- measles, mumps, rubella<br />

51


Human immunodeficiency virus (HIV)<br />

• 1983, HIV was correlated with<br />

AIDS (acquired immunodeficiency<br />

syndrome)<br />

• A retrovirus (an RNA virus)<br />

believed to have evolved in Africa<br />

from a monkey virus<br />

• 2006 CDC estimation:<br />

• ~ 1 million HIV infections in USA<br />

• Converging HIV and MDR-TB (multidrug<br />

resistance tuberculosis) Outbreaks<br />

Worsen


Figure 37.7<br />

HIV


Transmission<br />

• Acquired and passed from person to person<br />

• when infected blood, semen or vaginal secretions<br />

come in contact with uninfected person’s broken skin<br />

or mucous membranes<br />

• Groups most at risk in descending order<br />

• homosexuals<br />

• intravenous drug users<br />

• heterosexuals with drug users and prostitutes<br />

• children of infected mothers and breast-fed infants<br />

• transfusion patients and transplant recipients


HIV pathogenesis<br />

• Once inside host, HIV<br />

gp120 envelope protein<br />

binds to host CD4+<br />

glycoprotein plasma<br />

membrane receptor on<br />

CD4 + cells<br />

Figure 37.8


Acquired Immune Deficiency<br />

Syndrome (AIDS)<br />

• caused by human immunodeficiency virus (HIV)<br />

• occurs world wide, causing the great pandemic of the<br />

second half of the twentieth century<br />

• retrovirus<br />

• theories on origin of disease<br />

• HIV-1 evolved from chimp virus SIVcpz<br />

• use of human blood products in chimps infected animals with<br />

HIV-1 precursor that evolved into SIVcpz


Course of Disease<br />

• some patients rapidly develop clinical<br />

AIDS; die within 2-3 years<br />

• some patients remain relatively healthy for<br />

at least 10 years post infection<br />

• in majority of patients HIV infection<br />

progresses to AIDS in 8-10 years


CDC classification for HIV-related stages<br />

• AIDS- fourth and last stage<br />

• immune system no longer able to defend<br />

against virus<br />

• definition of AIDS<br />

• all HIV-infected individuals who has fewer<br />

than 200 CD4 + T cells/microliter of blood or a<br />

CD4 + cell percentage of lymphocytes of less<br />

than 14


AIDS-related cancers<br />

• Kaposi’s sarcoma<br />

• caused by human herpesvirus 8<br />

• carcinoma of mouth and rectum<br />

• B-cell lymphomas


AIDS-related central nervous system disease<br />

• headaches, fever, subtle cognitive changes,<br />

abnormal reflexes, and ataxia<br />

• dementia and severe sensory and motor<br />

changes observed in advanced cases<br />

• autoimmune neuropathies, cerebrovascular<br />

disease, and brain tumors are common


61<br />

Viral Hepatitis<br />

• hepatitis<br />

• inflammation of liver<br />

• caused by different viruses<br />

• Epstein-Barr virus (EBV)<br />

• cytomegalovirus (CMV)<br />

• cause mild, self-resolving disease<br />

• no permanent hepatic damage<br />

• signs and symptoms include<br />

fatigue, nausea, and malaise<br />

• hepatotropic viruses (HAV, HBV, HCV,<br />

HDV, HEV, HGV, and ?)


Hepatotropic viruses<br />

Table 37.4


Acute viral Gastroenteritis<br />

• Food-borne and<br />

waterborne diseases<br />

• Inflammation of<br />

stomach or intestines<br />

• important disease of<br />

infants and children,<br />

leading cause of<br />

childhood death in<br />

developing countries<br />

• probably spread by<br />

fecal-oral route<br />

Figure 37.21 Rotavirus


Enterovirus 71 (1998~ )<br />

• An RNA virus<br />

• Typical cold symptoms<br />

• mild enteric disease<br />

• hand, foot, and mouth disease<br />

• CNS (central nervous syndrome) diseases


Zoonotic (Animal-Borne) Diseases<br />

• human viral infections in animal reservoirs<br />

before transmission to and between humans<br />

• many are on Select Agents list as potential<br />

bioweapons<br />

• Ebola and Marburg viruses<br />

• hantaviruses<br />

• Lassa fever virus<br />

• Nipah virus<br />

bio-safety P4 level


Filoviridae- Marburg and Ebola virus<br />

• Ebola hemorrhagic fever<br />

• A severe and often fatal<br />

disease in human or<br />

nonhuman primates<br />

• 1 st recognition- 1976<br />

• 4 subtypes:<br />

• Humans- Ebola-Zaire, Ebola-<br />

Sudan, and Ebola-Ivory Coast<br />

• Nonhuman Primates- Ebola-<br />

Reston<br />

An RNA virus<br />

-1967, Marburg<br />

-1976, Ebola/Zaire<br />

66


Hantavirus Pulmonary Syndrome<br />

• An outbreak occurred in<br />

May 1993 in the Four<br />

Corners (New Mexico, Arizona,<br />

Colorado, and Utah)<br />

• The deer mouse- the<br />

principal carrier (climate<br />

changes)<br />

• Navajo Indian<br />

• No person to person spread<br />

• cause hemorrhagic fever<br />

67


Smallpox (Variola)<br />

• smallpox virus<br />

• A re-emerging disease:<br />

“Biological weapon”<br />

• transmitted by aerosol<br />

or contact<br />

• humans are only<br />

reservoir<br />

• 30% fatality<br />

68

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!